Immune-boosting treatments like checkpoint inhibitors have revolutionized the treatment of many cancers, but they don’t work for all patients. Now there’s a push underway in oncology research to identify immune-system biomarkers that could help oncologists predict which patients are most likely to respond well to particular immuno-oncology treatments.
Thanks to new technology, it’s becoming easier to profile the immune properties of the tumor microenvironment. Diagnostics used to measure immune response in blood samples are also improving.
During this Fierce webinar, experts in diagnostics, immunotherapy and oncology drug development will cover the latest advances in immune profiling, and provide advice on how biopharma companies can incorporate these developments into their R&D programs.
Date: Thursday, November 11, 2021
Time: 11am ET / 8am PT
Duration: 1 Hour
Register now for this webinar